THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT AND DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY OUTSIDE INDIA.

DACHEPALLI PUBLISHERS LIMITED

CIN- U22110TG1998PLC028994

Our Company was originally incorporated at Hyderabad, Andhra Pradesh as "Dachepalli Publishers Private Limited" on 3rd March, 1998 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad. Consequent upon the conversion of our Company to public limited company, the name of our Company was changed to "Dachepalli Publishers Limited" vide fresh certificate of incorporation dated 29th July, 2024 issued by the Central Processing Centre, Haryana. For further details please refer to chapter titled "History and Certain Corporate Matters" beginning on page 163 of this Prospectus.

The Equity Shares offered through the Red-Herring Prospectus are proposed to be listed on the SME Platform of BSE Limited ("BSE SME"). Our Company has received in-principle approval from BSE for listing of the Equity Shares pursuant to its letter dated 28th August, 2025. For the purposes of this Issue, BSE shall be the Designated Stock Exchange. The trading is proposed to be commenced on or about Tuesday, December 30,2025 (Subject to receipt of listing and trading approvals from BSE).

• Our business operations are majorly concentrated in certain geographical regions and any adverse developments affecting our operations in these regions could have a significant impact on our revenue and results of operations.

• We are dependent on third-party distributors, representatives and dealers for a substantial portion of our sales and any discontinuance from sales orders from any customer may affect our operations and could have an impact on our revenue and results of operations.

• We have experienced negative cash flows and any negative cash flows in the future could adversely affect our financial conditions and results of operations.

• Our Manufacturing facility is not owned by us. In the event we lose such rights, our Business, Financial Condition and Results of Operations and Cash Flows could be adversely affected.

• Our ability to enforce our intellectual property and proprietary rights may be limited, and any increase in unauthorized copying and distribution of our productions could harm our competitive position and materially adversely affect our business and results of operations.

• Average Cost of Acquisition of Equity Shares by our Promoters:

• Weighted average cost of acquisition of all shares transacted in (i) last one (1) year; (ii) last eighteen (18) months and (iii) last three (3) years preceding the date of this Prospectus.

• Weighted average cost of acquisition, floor price and cap price in the last 18 months

This Issue is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBIICDR Regulations wherein not more than 50.00% of the Net Issue shall be available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company in consultation with the BRLM may allocate up to 60.00% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion"). Forty per cent of the anchor investor portion shall be reserved as under: (i) 33.33% for domestic mutual funds; and (ii) 6.67 % for life insurance companies and pension funds, in accordance with the SEBI ICDR Regulations. In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the QIB Portion (other than the Anchor Investor Portion) ("Net QIB Portion"). Further, 5.00% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Issue shall be available for allocation on a proportionate basis to Non- Institutional Investors and not less than 35.00% of the Net Issue shall be available for allocation to Retail Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. All Potential Bidders, other than Anchor Investors, are required to participate in the Issue by mandatorily utilising the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts will be blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Issue through the ASBA process. For details, please refer to the chapter titled "Issue Procedure" on page 262 of this Prospectus.

The Bid/Issue opened for Anchor portion opened and closed Friday, December 19, 2025. The Bid/Issue opened for public on Monday, December 22, 2025 and closed on Wednesday, December 24, 2025.

Details of Anchor Investors: The Company has received 05 Anchor Investor Application Forms from 05 Anchor Investors for 12,57,600 Equity Shares. Such 05 Anchor Investors through 05 Anchor Investor Application Forms were allocated 11,25,600 Equity Shares at a price of Rs. 102/- per Equity Share under the Anchor Investor Portion, aggregating to Rs. 11,48,11,200.00/-.

The Issue was subscribed to the extent of 3.64 times (including market maker reservation portion and excluding anchor investor portion) as per the Application data before considering invalid bids, after removing multiple and duplicate bids. The issue (excluding Anchor Investor Portion) received 1,243 applications for 54,51,600 Equity Shares before technical rejections and after invalid bids Multiple/Duplicate/bids, UPI Mandates not accepted by investors, bids rejected under application banked but bid not registered resulting in 1.92 times subscription (including reserved portion of market maker). After removing valid rejections cases from the "Bid Book", the issue was subscribed by 1.89 times (excluding the Anchor Investor Portion). The details of the break-up of rejections from the bid book under the various heads are as mentioned below:

The details of the applications received in the Issue from various categories:

A summary of the final demand as per BSE as on the Bid/Issue Closing Date at different Bid prices is as under:

ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being BSE on December 26, 2025.

A. Allocation to Individual Investors (After Technical Rejections) (including ASBA applications): The Basis of Allotment to the Individual Investors, who have bid at the Cut-Off Price or at the Issue Price of Rs. 102 per Equity Share, was finalized in consultation with the BSE. This category has been subscribed to the extent of 1.87 times. The total number of Equity Shares Allotted in Individual Investor Portion is 1317600 Equity Shares to 549 successful Individual Investors. The category-wise details of the Basis of Allotment are as under:

B. Allocation to Non-Institutional Investors up to Rs. 10,00,000 (Alter Technical Rejections): The Basis of Allotment to the Individual Investor upto Rs. 10,00,000, who have bid at the Issue Price of Rs. 102 per Equity Share, was finalized in consultation with BSE. This category has been subscribed to the extent of 2.20 times (after rejections). The total number of Equity Shares allotted in this category is 188400 Equity Shares to 52 successful to Individual Investor upto Rs. 10,00,000. The category-wise details of the Basis of Allotment is as under:

C. Allocation to Non-Institutional Investors above Rs. 10,00,000 (After Technical Rejections): The Basis of Allotment to the Institutional Investors above Rs. 10,00,000, who have bid at the Issue Price of Rs. 102 per Equity Share, was finalized in consultation with BSE. This category has been subscribed to the extent of 3.50 times (after rejections). The total number of Equity Shares allotted in this category is 376800 Equity Shares to 101 successful Institutional Investors above Rs. 10,00,000. The category-wise details of the Basis of Allotment is as under:

D. Allotment to QIBs (after rejections): Allotment to QIBs, who have Bid at the Issue Price of Rs. 102 per Equity Share or above, has been done on a proportionate basis in consultation with the BSE. This category has been subscribed to the extent of 1.26 times of QIB Portion. The total number of Equity Shares Allotted in the QIB Portion is 752400 Equity Shares which were allotted to 02 successful QIB Investors. The category-wise details of the Basis of Allotment are as under:

E. Allocation to Market Maker (After Technical Rejections): The Basis of Allotment to the Market Maker, at the issue price of Rs. 102 Equity Share, was finalized in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category 199200 Equity Shares to 01 successful applicant.

The Board of Directors of the Company at its meeting held on December 26, 2025 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange and has authorized the corporate action for the transfer of the Equity Shares to various successful applicants.

The refund / allotment intimation will be dispatched to the address of the Applicants as registered with the depositories on or about December 29, 2025. Further, the instructions to Self-Certified Syndicate Banks for unblocking the amount will be processed on or prior to December 29, 2025. In case the same is not received within ten days, investors may contact Registrar at the address given below.

The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on BSE within three working days from the date of the closure of the Issue.

Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the Prospectus dated December 26, 2025 ("Prospectus").

This is the first issue of the Book Running Lead Manager associated with the Issue and has not handled any SME or Main Board Issue in the past.

The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Bigshare Services Private Limited at www.bigshareonline.com.

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

Dachepalli Publishers Limited has filed the Prospectus with RoC and the Stock Exchanges on 26th December, 2025. The Prospectus is expected to be available on the website of SEBI at www.sebi.gov.in, the websites of the Stock Exchanges i.e. BSE at www.bseindia.com, respectively, the website of the Company at www.dachepalli.com and on the websites of the Book Running Lead Manager ("BRLM"), www.synfinx.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see "Risk Factors'' beginning on page 29 of the Prospectus. Potential investors should not rely on the Prospectus filed with SEBI and the Stock Exchanges, and should instead rely on their own examination of our Company and the Issue, including the risks involved, for making any investment decision. This announcement does not constitute an offer of securities for sale in any jurisdiction, including the United States, The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended ("U.S. Securities Act") or any state securities laws in the United States, and unless so registered, may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in the United States solely to "qualified institutional buyers" (as defined in Rule 144A under the U.S. Securities Act) in transactions exempt from or not subject to the registration requirements of the U.S. Securities Act and (b) outside the United States in "offshore transactions" as defined in and in reliance on Regulation of the U.S. Securities Act and the applicable laws of each jurisdiction where such offers and sales are made.